Search for: All records

Inspired by Nature, we present a polypeptide-based organic redox-active material constructed from renewable feedstocks, L-glutamic acid (an amino acid) and riboflavin (vitamin B₂), to address challenges with start-to-end-of-life management in energy storage systems (ESSs). The amino acid was utilized to establish a degradable polymer backbone, along which many copies of riboflavin were incorporated to serve as the redox-active pendant groups that enabled energy storage. The overall synthesis involved the ring-opening polymerization (ROP) of anl-glutamic acid-derivedN-carboxyanhydride (NCA) monomer, followed by side chain activation with azides and, finally, click coupling to achieve installation of alkyne-functionalized riboflavin moieties. The steric bulkiness and rich chemical functionality of riboflavin resulted in synthetic complexities that required reaction optimization to achieve the desired polymer structure. Electrochemical characterization of the resultant riboflavin polypeptide, in organic electrolyte, showed quasireversible redox activity with a half-wave potential (E_1/2) ofca.−1.10 Vvs.ferrocene/ferrocenium (Fc/Fc⁺). Cell viability assays revealed biocompatibility, as indicated by negligible cytotoxicity for fibroblast cells. The polypeptide design, consisting of labile amide backbone linkages and side-chain ester functionalities that tethered the riboflavin units to the backbone, enabled hydrolytic degradation to recover building blocks for future upcycling or recycling. This bioinspired strategy advances the development of degradable redox-active polymers and promotes sustainable materials design for circular energy storage technologies. 

Non-aqueous organic redox flow batteries (NAORFBs) are considered emerging large-scale energy storage systems due to their larger voltage window as compared to aqueous systems and their metal-free nature. However, low solubility, sustainability, and crossover of redox materials remain major challenges for the development of NAORFBs. Here, we report the use of redox active α-helical polypeptides suitable for NAORFBs. The polypeptides exhibit less crossover than small molecule analogs for both Daramic 175 separator and FAPQ 375 PP membrane, with FAPQ 375 PP preventing crossover most effectivley. Polypeptide NAORFBs assembled with a TEMPO-based polypeptide catholyte and viologen-based polypeptide anolyte exhibit low capacity fade ( ca. 0.1% per cycle over 500 cycles) and high coulombic efficiency (>99.5%). The polypeptide NAORFBs exhibit an output voltage of 1.1 V with a maximum capacity of 0.53 A h L −1 (39% of the theoretical capacity). After 500 charge–discharge cycles, 60% of the initial capacity was retained. Post cycling analysis using spectral and electrochemical methods demonstrate that the polypeptide backbone and the ester side chain linkages are stable during electrochemical cycling. Taken together, these polypeptides offer naturally-derived, deconstructable platforms for addressing the needs of metal-free energy storage. 

Synthetic transformation of d -xylose into a four-membered cyclic ether allows for reactions with carbon dioxide (CO 2 ) leading to linear polycarbonates by either a one-step ring-opening copolymerisation (ROCOP) directly, or by sequential isolation of a preformed six-membered cyclic carbonate followed by ring-opening polymerisation (ROP). 

The role of the linker (the group connecting viologen moieties to peptide-based backbones) in electron transfer was studied. The backbone dictated the mechanism of electron transfer, whereas the linker length altered the rate of electron transfer. 

Hemorrhage is a prime cause of death in civilian and military traumatic injuries, whereby a significant proportion of death and complications occur prior to paramedic arrival and hospital resuscitation. Hence, it is crucial to develop hemostatic materials that are able to be applied by simple processes and allow control over bleeding by inducing rapid hemostasis, non-invasively, until subjects receive necessary medical care. This tutorial review discusses recent advances in synthesis and fabrication of degradable hemostatic nanomaterials and nanocomposites. Control of assembly and fine-tuning of composition of absorbable ( i.e. , degradable) hemostatic supramolecular structures and nanoconstructs have afforded the development of smart devices and scaffolds capable of efficiently controlling bleeding while degrading over time, thereby reducing surgical operation times and hospitalization duration. The nanoconstructs that are highlighted have demonstrated hemostatic efficiency pre-clinically in animal models, while also sharing characteristics of degradability, bioabsorbability and presence of nano-assemblies within their compositions.